Wednesday, July 29, 2015 7:28:56 AM
Is the company up for sale? If not, I think you should consider a paradigm shift; transfer your operation to India's Bengaluru high tech region and apply your skills to the pharma and medical industries. Costs in India are considerably lower than Hong Kong (or anywhere else) and there is an unlimited supply of computer professionals to draw from. There are all kinds of AI/AR applications for drug discovery and development simulation software. There is also the opportunity to invent patient apps that supplement drug intake regimens and to enhance drug efficacy.
Give it some thought.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM